← Open Payments lookup

RIMI SANDHU: Open Payments

NPI 1770287203 · SPRING, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,986 in 160 payments from 21 companies in 2025. Trend: 2023 $106 · 2024 $2,210 · 2025 $2,986

Food & beverage: $2,976Education: $10
CompanyPaymentsAmount
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)24$508
ABBVIE INC.37$507
E.R. Squibb & Sons, L.L.C.10$267
Axsome Therapeutics, Inc.15$249
Corium, LLC11$188
Otsuka America Pharmaceutical, Inc.10$183
Lundbeck LLC11$182
Teva Pharmaceuticals USA, Inc.5$164
Supernus Pharmaceuticals, Inc.9$162
Neurocrine BioSciences, Inc.4$108

Products named: CAPLYTA, VRAYLAR, REXULTI, COBENFY, Auvelity, Azstarys, Qelbree, AUSTEDO XR.

Industry payments across TX — which companies pay providers there.